BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30285131)

  • 1. Reduced Opioid Marketing Could Limit Prescribing Information for Physicians.
    Ippolito B; Veuger S
    JAMA Intern Med; 2018 Oct; 178(10):1427. PubMed ID: 30285131
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced Opioid Marketing Could Limit Prescribing Information for Physicians-Reply.
    Hadland SE; Cerdá M; Marshall BDL
    JAMA Intern Med; 2018 Oct; 178(10):1426-1427. PubMed ID: 30285139
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes.
    Erdek MA
    AMA J Ethics; 2020 Aug; 22(1):E681-686. PubMed ID: 32880356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US governors seek to limit opioid prescribing.
    Dyer O
    BMJ; 2016 Feb; 352():i1144. PubMed ID: 26912533
    [No Abstract]   [Full Text] [Related]  

  • 9. Restricting interactions with industry to promote evidence-based prescribing.
    Ross JS
    JAMA Intern Med; 2014 Aug; 174(8):1290. PubMed ID: 24912054
    [No Abstract]   [Full Text] [Related]  

  • 10. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid analgesics--risky drugs, not risky patients.
    Dowell D; Kunins HV; Farley TA
    JAMA; 2013 Jun; 309(21):2219-20. PubMed ID: 23700072
    [No Abstract]   [Full Text] [Related]  

  • 13. Doctors are urged to limit opioid prescribing.
    McCarthy M
    BMJ; 2016 Mar; 352():i1614. PubMed ID: 26993363
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing of opioid analgesia.
    Jones J; Lavies NG
    Anaesthesia; 1998 Mar; 53(3):308-9. PubMed ID: 9613281
    [No Abstract]   [Full Text] [Related]  

  • 15. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Opioid Prescribing Behaviors: A Time for Institutional and Regulatory Changes.
    Cheatle MD
    Pain Med; 2017 May; 18(5):823-824. PubMed ID: 28431089
    [No Abstract]   [Full Text] [Related]  

  • 17. Dispute over use of MDs' prescribing information heading to court.
    Sibbald B
    CMAJ; 2003 Feb; 168(3):325. PubMed ID: 12566344
    [No Abstract]   [Full Text] [Related]  

  • 18. A physician's response to observational studies of opioid prescribing.
    Mandell BF
    Cleve Clin J Med; 2018 Nov; 85(11):824-825. PubMed ID: 30395518
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid Prescribing by Emergency Physicians and Risk of Long-Term Use.
    Beaudoin FL; Rich JD
    N Engl J Med; 2017 May; 376(19):1895-6. PubMed ID: 28492072
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid Prescribing by Emergency Physicians and Risk of Long-Term Use.
    Menchine M; Kea B
    N Engl J Med; 2017 May; 376(19):1895. PubMed ID: 28489998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.